ArticleDiabetology & metabolic syndrome2022

Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice.

Amal M Mahfoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.